Filing Details
- Accession Number:
- 0001651308-19-000103
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-11-05 16:22:06
- Reporting Period:
- 2019-11-01
- Accepted Time:
- 2019-11-05 16:22:06
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1651308 | Beigene Ltd. | BGNE | Pharmaceutical Preparations (2834) | 981209416 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1662982 | Xiaodong Wang | C/O Mourant Governance Services (Cayman) 94 Solaris Avenue Camana Bay, Grand Cayman E9 KY1-1108 | Yes | No | No | Yes |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
American Depositary Shares | Disposition | 2019-11-01 | 1,000 | $170.00 | 0 | No | 4 | S | Direct | |
American Depositary Shares | Disposition | 2019-11-04 | 1,000 | $190.00 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Ordinary Shares | 7,585,628 | Direct | |
Ordinary Shares | 224,372 | Indirect | See Footnote |
Ordinary Shares | 4,948,000 | Indirect | See Footnote |
Footnotes
- These securities are held in a UTMA account for the Reporting Person's minor child, for which the Reporting Person disclaims beneficial ownership.
- These securities are held by Wang Investment LLC, of which 99% of the limited liability company interest is owned by two grantor retained annuity trusts, of which the Reporting Person's wife is a trustee, for which the Reporting Person disclaims beneficial ownership.
- Each American Depositary Share represents 13 Ordinary Shares.
- The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.